🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fostering Data Sharing

Search Papers Authors Institutions Grants FAIR About

TheSindex

Fostering Data Sharing

Empowering the data sharing that empowers science — an open, citation-grounded index for datasets.

Product

Search
API
Explore
Rankings

Resources

Methodology
Data Sources
Documentation
Press

Organization

About
Team
Wikidata

© 2026 theSindex. All rights reserved.

Home
Authors
Josef S Smolen

Josef S Smolen

Medical University of Vienna

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative”.

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

Arthritis & Rheumatism(2010)10.1002/art.27584

N/A

1.4DataRank · unranked

9467 citations

Tuhina Neogi, Alan J. Silman, Julia Funovits, David T. Felson, Clifton O. Bingham +32 more

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics

Annals of the Rheumatic Diseases(2008)10.1136/ard.2007.070367

N/A

0.994DataRank · unranked

753 citations

J. Boletis, S Bombardieri, R Cervera, C Dostal, J Font +28 more

EULAR points to consider for conducting clinical trials in systemic lupus erythematosus

Annals of the Rheumatic Diseases(2009)10.1136/ard.2007.083022

N/A

0.542DataRank · unranked

36 citations

G K Bertsias, J. Boletis, S Bombardieri, R Cervera, C Dostal +30 more

EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints

Annals of the Rheumatic Diseases(2009)10.1136/ard.2007.083030

N/A

0.515DataRank · unranked

30 citations

J. Boletis, S Bombardieri, R Cervera, C Dostal, J Font +30 more

Influence of study characteristics on harm estimates from randomised controlled trials in patients with inflammatory arthritis receiving biological or synthetic antirheumatic drugs: a meta-epidemiological study

Annals of the Rheumatic Diseases(2025)10.1136/ard-2024-226129

N/A

0.165DataRank · unranked

2 citations

Sabrina Mai Nielsen, Esben Malm, Daniel E. Furst, Josef S Smolen, Peter C. Taylor +7 more

Risk of harm in synthetic and biological intervention trials in patients with inflammatory arthritis: protocol for a metaepidemiological study focusing on contextual factors

BMJ Open(2021)10.1136/bmjopen-2021-049850

N/A

0.104DataRank · unranked

1 citations

Sabrina Mai Nielsen, Johannes I. Berg, John P. A. Ioannidis, Josef S Smolen, Peter C. Taylor +6 more